Amgen Inc. Common Stock (1AMGN)

Profile

https://www.amgen.com

Amgen Inc. is a global biotechnology company that discovers, develops, manufactures, and commercializes human therapeutics. Its current portfolio focuses on serious diseases across oncology, cardiovascular disease, inflammation, bone health, nephrology, and rare diseases, with medicines delivered through biologics such as recombinant proteins and monoclonal antibodies. Amgen works with healthcare providers, hospitals, pharmacies, and wholesalers, serving patients in developed markets worldwide. The company’s role in the financial market is closely tied to its branded biologic medicines and research-driven product pipeline, which support its position as one of the leading independent biotechnology companies. Headquartered in Thousand Oaks, California, Amgen combines large-scale manufacturing and global distribution with a strong emphasis on innovative treatments for conditions with high unmet medical need.